PFG
50
-3
CA
4
-3
PG
68
4
MA
72
-2
VRSK
73
-4
VFC
59
-2
MRK
43
2
LOW
59
-2
AMZN
58
-2
ICE
64
-2
OXY
45
-3
WBA
41
-2
UAL
51
-3
LRCX
59
-3
FRT
56
-2
ACN
58
2
AES
45
-4
MAR
72
-5
SJM
29
5
LNC
49
-4
PFG
50
-3
CA
4
-3
PG
68
4
MA
72
-2
VRSK
73
-4
VFC
59
-2
MRK
43
2
LOW
59
-2
AMZN
58
-2
ICE
64
-2
OXY
45
-3
WBA
41
-2
UAL
51
-3
LRCX
59
-3
FRT
56
-2
ACN
58
2
AES
45
-4
MAR
72
-5
SJM
29
5
LNC
49
-4
Financhill
Back

NovoCure Stock Predictions

Is the Traditional House Obsolete?

Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.
Sell
40

NVCR
NovoCure

Last Price:
$17.77
Seasonality Move:
11%

7 Day Trial

ALL ACCESS PASS

$ 7

Your Portfolio's Boring. This Company Isn't And It's Early

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai. *RAD Intel recently received their ticker reservatio

NovoCure Stock Forecast

  • Over the next 52 weeks, NovoCure has on average historically risen by 33.8% based on the past 9 years of stock performance.
  • NovoCure has risen higher in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%
  • Is NovoCure Stock Undervalued?
    The current NovoCure [NVCR] share price is $18.20. The Score for NVCR is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • NVCR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will NovoCure Stock Go Up Next Year?

  • Over the next 52 weeks, NovoCure has on average historically risen by 33.8% based on the past 9 years of stock performance.

NovoCure Stock Rating

Sell
40
NovoCure (NVCR) is a Sell

Is NovoCure overpriced?

  • NovoCure has risen higher in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%

NovoCure Stock Price History

Is NVCR stock going to rise?

  • The current trend is relatively stagnant and NVCR is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Jersey
Industry:
Health Care Equipment & Supplies
Sector:
Health Care
Type:
stock
Website:
novocure.com

52-Week Data

52-Week High:
34.13
52-Week Low:
14.17

Prediction Charts

Market Cap:
2B
Price in USD:
18.20
Volume:
1.1M
Beta:
1.05

Technical Analysis

SMA50:
17.89
SMA100:
21.40
SMA200:
20.31
52-Wk Change:
-24.32%

Stock Predictions

  • Is NovoCure stock public?
    Yes, NovoCure is a publicly traded company.
  • What is the NovoCure stock quote today?
    The NovoCure stock price is 18.20 USD today.
  • How to buy NovoCure stock online?
    You can buy NovoCure shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-1 18.28 17.95 18.40 17.47
May-2 18.31 18.15 18.52 18.14
May-5 18.15 17.76 18.15 17.61
May-6 17.55 16.33 17.57 16.31
May-7 16.58 16.65 16.72 16.19
May-8 16.96 17.44 17.70 16.85
May-9 17.52 17.38 17.69 17.20
May-12 17.97 18.57 18.77 17.93
May-13 18.79 18.14 18.85 17.86
May-14 18.11 17.10 18.11 16.92
May-15 17.17 17.59 17.62 16.67
May-16 17.60 17.89 17.94 17.34
May-19 17.50 17.96 17.99 17.38
May-20 17.89 18.20 18.30 17.71

NovoCure Earnings

NovoCure Earnings Report: Per Share NovoCure Earnings Q1 Q2 Q3 and Q4 last year and next year.

NovoCure Forecast Revenue Growth

NovoCure Stock Analysis: Historical quarterly revenues per share for NovoCure and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, an increase next quarter of $0.01 per share, a decrease this year of $0.35 per share, and a decrease next year of $0.10 per share.

* NovoCure stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.